These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31109263)

  • 1. Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England.
    Kasteridis P; Ride J; Gutacker N; Aylott L; Dare C; Doran T; Gilbody S; Goddard M; Gravelle H; Kendrick T; Mason A; Rice N; Siddiqi N; Williams R; Jacobs R
    Psychiatr Serv; 2019 Aug; 70(8):650-656. PubMed ID: 31109263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Evidence of Antipsychotic Monotherapy Versus Polypharmacy in the Treatment of Schizophrenia Spectrum Disorders.
    Korkmaz ŞA; Koca E; Yilmaz Ö; Özbek T; Güçlü MA; Kizgin S
    J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):250-257. PubMed ID: 38489589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.
    Kadra G; Stewart R; Shetty H; Jackson RG; Greenwood MA; Roberts A; Chang CK; MacCabe JH; Hayes RD
    BMC Psychiatry; 2015 Jul; 15():166. PubMed ID: 26198696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.
    Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR
    Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient Hospitals.
    Ortiz G; Hollen V; Schacht L
    J Psychiatr Pract; 2016 Jul; 22(4):283-97. PubMed ID: 27427840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality risk from long-term treatment with antipsychotic polypharmacy vs monotherapy among adults with serious mental illness: A systematic review and meta-analysis of observational studies.
    Buhagiar K; Templeton G; Blyth H; Dey M; Giacco D
    Schizophr Res; 2020 Sep; 223():18-28. PubMed ID: 32948381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
    Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
    JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Academic Detailing With Audit and Feedback to Improve Antipsychotic Pharmacotherapy.
    Brunette MF; Cotes RO; de Nesnera A; McHugo G; Dzebisashvili N; Xie H; Bartels SJ
    Psychiatr Serv; 2018 Sep; 69(9):1021-1028. PubMed ID: 29879874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
    Li C; Mittal D; Owen RR
    Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic utilisation and polypharmacy in Italian residential facilities: a survey.
    Ghio L; Natta W; Gotelli S; Ferrannini L;
    Epidemiol Psychiatr Sci; 2011 Jun; 20(2):171-9. PubMed ID: 21714364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic Medication and Risk of Metabolic Disorders in People With Schizophrenia: A Longitudinal Study Using the UK Clinical Practice Research Datalink.
    Eyles E; Margelyte R; Edwards HB; Moran PA; Kessler DS; Davies SJC; Bolea-Alamañac B; Redaniel MT; Sullivan SA
    Schizophr Bull; 2024 Mar; 50(2):447-459. PubMed ID: 37622178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world effectiveness of antipsychotic monotherapy vs. polypharmacy in schizophrenia: to switch or to combine? A nationwide study in Hungary.
    Katona L; Czobor P; Bitter I
    Schizophr Res; 2014 Jan; 152(1):246-54. PubMed ID: 24275583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident users of antipsychotics: who are they and how do they fare?
    Baandrup L; Kruse M
    Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):505-12. PubMed ID: 26409887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality.
    Kadra G; Stewart R; Shetty H; MacCabe JH; Chang CK; Taylor D; Hayes RD
    Acta Psychiatr Scand; 2018 Aug; 138(2):123-132. PubMed ID: 29845597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia.
    Caroff SN; Mu F; Ayyagari R; Schilling T; Abler V; Carroll B
    BMC Psychiatry; 2018 Sep; 18(1):306. PubMed ID: 30249218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antipsychotic prescribing and association with neighbourhood-level socioeconomic status: analysis of time trend of routine primary care data in England, 2011-2016.
    Buhagiar K; Ghafouri M; Dey M
    Soc Psychiatry Psychiatr Epidemiol; 2020 Feb; 55(2):165-173. PubMed ID: 31630215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do care plans and annual reviews of physical health influence unplanned hospital utilisation for people with serious mental illness? Analysis of linked longitudinal primary and secondary healthcare records in England.
    Ride J; Kasteridis P; Gutacker N; Kronenberg C; Doran T; Mason A; Rice N; Gravelle H; Goddard M; Kendrick T; Siddiqi N; Gilbody S; Dare CR; Aylott L; Williams R; Jacobs R
    BMJ Open; 2018 Nov; 8(11):e023135. PubMed ID: 30498040
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.